Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | TXT | Hongjian Jin | ||||||
GSE108362 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects [RNA-seq]
|
41 |
|
Hongjian Jin | Jan 03, 2019 | |||
GSE115873 |
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo [RNA-Seq]
|
50 |
|
Hongjian Jin | Mar 18, 2019 | |||
GSE151514 |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy [RNA-seq]
|
9 |
|
Hongjian Jin | Dec 21, 2020 | |||
GSE151598 |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy
|
21 |
|
Hongjian Jin | Dec 22, 2020 | |||
GSE157095 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma
|
104 |
|
Hongjian Jin | Sep 06, 2022 | |||
GSE164455 |
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [RNA-seq]
|
33 |
|
Hongjian Jin | Mar 04, 2024 | |||
GSE164456 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
69 |
|
Hongjian Jin | Mar 02, 2024 | |||
GSE164505 |
Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam (RNA-Seq)
|
28 |
|
Hongjian Jin | Nov 24, 2021 | |||
GSE164506 |
Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam
|
34 |
|
Hongjian Jin | Nov 24, 2021 | |||
GSE166808 |
Quantitative assessment of transcriptomic differences between ASPcKO and ASPcKOP7cKO flow cytometry-sorted murine FN-RMSs by RNA sequencing
|
8 |
|
Hongjian Jin | Aug 24, 2021 | |||
GSE166906 |
Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
|
29 |
|
Hongjian Jin | Aug 24, 2021 | |||
GSE172221 |
A genetic mouse model of malignant peripheral nerve sheath tumor with postnatal Nf1 and p53 loss recapitulates the histology and transcriptome of human tumors
|
44 |
|
Hongjian Jin | Mar 24, 2024 | |||
GSE193124 |
Genome-wide mapping of oncogenic pathways and genetic modifiers of chemotherapy using a high-risk hepatoblastoma genetic model
|
6 | Hongjian Jin | Jun 22, 2023 | ||||
GSE198755 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [RNA-Seq]
|
4 | Hongjian Jin | Sep 06, 2022 | ||||
GSE201224 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [RNAseq_LHCN_hg19]
|
4 | Hongjian Jin | Sep 06, 2022 | ||||
GSE207013 |
RNA-seq of KDM4A, B and C siRNA knockdown in NB cells
|
24 | Hongjian Jin | Mar 04, 2024 | ||||
GSE207035 |
KDM4 histone lysine demethylases maintain the adrenergic core regulatory circuitry programed by MYCN in neuroblastoma
|
30 |
|
Hongjian Jin | Mar 02, 2024 | |||
GSE218274 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity
|
75 | Hongjian Jin | Sep 29, 2023 | ||||
GSE218357 |
PAX3-FOXO1 drives tumor formation from multiple lineages [RNA-seq]
|
31 | Hongjian Jin | Sep 30, 2023 | ||||
GSE253185 |
Credentialling a c-MYC-driven genetic neuroblastoma model
|
5 |
|
Hongjian Jin | Nov 05, 2024 |